Quoting:<p>> CimaVax was developed by government-run Molecular Immunology Center. It's not brand new, and Cuba has not kept its success a secret. Cuban researchers were testing the drug in the 1990s and major world media outlets have reported on it in the 2000s.<p>In addition, quoting from <a href="http://en.wikipedia.org/wiki/Health_care_in_Cuba#Medical_research" rel="nofollow">http://en.wikipedia.org/wiki/Health_care_in_Cuba#Medical_res...</a> :<p>> In the 1980s, Cuban scientists developed a vaccine against a strain of bacterial meningitis B, which eliminated what had been a serious disease on the island. The Cuban vaccine is used throughout Latin America. After outbreaks of meningitis B in the United States, the U.S. Treasury Department granted a license in 1999 to an American subsidiary of the pharmaceutical company SmithKline Beecham to enter into a deal to develop the vaccine for use in the U.S. and elsewhere<p>Or <a href="http://www.globalresearch.ca/cuba-develops-four-cancer-vaccines-ignored-by-the-media/5390303" rel="nofollow">http://www.globalresearch.ca/cuba-develops-four-cancer-vacci...</a> :<p>> it is important to note that the US economic blockade of Cuba hinders the marketing of Cuban pharmaceuticals in the United States, thus affecting the US people. For instance, a total of 80 thousand diabetic people who undergo toe amputation every year in the United States every year cannot access the Cuban vaccine known as Heberprot-P, which precisely avoids such amputations.<p>Cuba's biotech research is used as an example of what pharmaceutical research might look like were it not profit-driven.